Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2025 Mar 3;192(3):K24-K29.
doi: 10.1093/ejendo/lvaf001.

Sex-dependent increases in oxytocin levels in response to intravenous kisspeptin in humans

Affiliations
Clinical Trial

Sex-dependent increases in oxytocin levels in response to intravenous kisspeptin in humans

Francesca Galbiati et al. Eur J Endocrinol. .

Abstract

Background: A clinically significant oxytocin-deficient state (OXT-D) has been established in adults with arginine vasopressin deficiency, and there is a need to develop diagnostic testing. Kisspeptin (KP) is a candidate for such a test, as KP receptors are found on oxytocinergic neurons, and KP administration increases plasma OXT in animals. We hypothesized that intravenous KP administration would increase peripheral OXT levels post-injection in healthy adults.

Methods: Kisspeptin-112-121 (KP analog, 0.24 nmol/kg bolus) was administered to 12 healthy adults (50% female). Serum OXT was measured before and 10, 20, 40, and 60 min after KP administration.

Results: Males and females did not differ significantly in age, BMI, or baseline OXT levels. Ten minutes after KP, OXT increased by 18.8% from baseline (FDR-P = .004) with a greater increase in males than females (31.9% vs 5.7%, respectively, FDR-P = .004).

Conclusions: Our data support KP as a candidate for a provocative test to identify OXT-D in males.

Clinical trial registration: Our study was registered on ClinicalTrials.gov (NCT00914823).

Keywords: kisspeptin; oxytocin deficiency; posterior pituitary; provocative test.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: F.P. and E.A.L. are inventors on US provisional patent application no. 63/467,980 (Oxytocin-based therapeutics to improve cognitive control in individuals with attention deficit hyperactivity disorder). K.K.M. has received study medication and investigator-initiated research grants from Amgen and has equity in Bristol-Myers Squibb (BMS), General Electric, Boston Scientific, and Becton Dickinson. S.B.S. has a financial interest in SeNa Therapeutics. E.A.L receives grant support and research study drug from Tonix Pharmaceuticals and receives royalties from UpToDate. E.A.L. and/or immediate family member holds stock in Thermo Fisher Scientific, Zoetis, Danaher Corporation, Intuitive Surgical, Merck and West Pharmaceutical Services.

References

    1. Arima H, Cheetham T, Christ-Crain M, et al. Changing the name of diabetes insipidus: a position statement of the working group for renaming diabetes insipidus. J Clin Endocrinol Metab. 2022;108(1):1–3. 10.1210/clinem/dgac547 - DOI - PMC - PubMed
    1. Aulinas A, Guarda FJ, Yu EW, et al. Lower oxytocin levels are associated with lower bone mineral density and less favorable hip geometry in hypopituitary men. Neuroendocrinology. 2021;111(1-2):87–98. 10.1159/000506638 - DOI - PMC - PubMed
    1. Aulinas A, Plessow F, Asanza E, et al. Low plasma oxytocin levels and increased psychopathology in hypopituitary men with diabetes insipidus. J Clin Endocrinol Metab. 2019;104(8):3181–3191. 10.1210/jc.2018-02608 - DOI - PMC - PubMed
    1. Atila C, Holze F, Murugesu R, et al. Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial. Lancet Diabetes Endocrinol. 2023;11(7):454–464. 10.1016/s2213-8587(23)00120-1 - DOI - PubMed
    1. Kerem L, Lawson EA. The effects of oxytocin on appetite regulation, food intake and metabolism in humans. Int J Mol Sci. 2021;22(14):7737. 10.3390/ijms22147737 - DOI - PMC - PubMed

Publication types

Associated data